Fernando Herz Wolff
Biographic Data
| ID | 5465856 |
|---|---|
| NAME | Fernando Herz Wolff |
| GIVEN NAMES | Fernando Herz |
| FAMILY NAME | Wolff |
| SIGNATURE | WOLFF F H |
| AFFILIATIONS | Universidade Federal do Rio Grande do Sul |
| ORCID | 0000-0003-2907-9210 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2011 |
| H-INDEX | 0 |
P2-76 Antibiotics for hepatic encephalopathy
Objective To assess the effectiveness of antibiotics in the treatment of hepatic encephalopathy (HE). Data sources Cochrane Hepato-Biliary Group controlled trials register, Cochrane Controlled Trials Register, MEDLINE, LILACS, SCI Expanded, Embase and http://clinicaltrials.gov/ until January 2010; reference lists of relevant articles and authors were searched. Review methods The methodological approach outlined in the Cochrane Handbook was follow…
SP2-9 Diagnostic criteria of lipodystrophy in HIV-infected patients
Introduction The prevalence of lipodystrophy ranges from 2 to 84% and the range of findings stems from differences between the populations studied and lack of standardised diagnostic criteria. The diagnosis of lipodystrophy is based on changes in body fat distribution with or without medical confirmation, objective measures of circumferences and skin folds or quantification of adiposity by dual emission x-ray absorptiometry (DEXA) CT scan or MRI.…
No prominent works on this page.
P2-76 Antibiotics for hepatic encephalopathy
Objective To assess the effectiveness of antibiotics in the treatment of hepatic encephalopathy (HE). Data sources Cochrane Hepato-Biliary Group controlled trials register, Cochrane Controlled Trials Register, MEDLINE, LILACS, SCI Expanded, Embase and http://clinicaltrials.gov/ until January 2010; reference lists of relevant articles and authors were searched. Review methods The methodological approach outlined in the Cochrane Handbook was follow…
SP2-9 Diagnostic criteria of lipodystrophy in HIV-infected patients
Introduction The prevalence of lipodystrophy ranges from 2 to 84% and the range of findings stems from differences between the populations studied and lack of standardised diagnostic criteria. The diagnosis of lipodystrophy is based on changes in body fat distribution with or without medical confirmation, objective measures of circumferences and skin folds or quantification of adiposity by dual emission x-ray absorptiometry (DEXA) CT scan or MRI.…
Internal Medicine (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Pathology (2 works) · Abdomen (1 work) · Alternative medicine (1 work) · Antibiotics (1 work) · Antiretroviral therapy (1 work) · Buttocks (1 work) · Cirrhosis (1 work)